Posterior Sub-Tenon Triamcinolone Injection for Chronic Macular Oedema Associated With Non-Ischemic Branch or Central Retinal Vein Occlusion
Journal Title: The Ophthalmology – Open Journal - Year 2016, Vol 1, Issue 1
Abstract
Aims: To evaluate the effectiveness and safety of Posterior Sub-Tenon (PST) Triamcinolone Acetonide (TA) injection for persistent macular oedema associated with non-ischemic Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO) in non-vitrectomized eye. Methods: Fourteen consecutive eyes of 14 patients characterized by macular oedema lasting more than 3 months and with a visual acuity of less than 20/40 were enrolled. Six eyes presented with BRVO, 8 eyes with CRVO. PST injection of 40 mg TA was performed in topical anaesthesia. All patients were phakic, and followed for at least 6 months. Snellen visual acuity converted to LogMAR units and anatomic responses were evaluated before, and at 1, 3, 6, and 12 (if required) months after injections and re-injection considered. Results: In the BRVO group, mean foveal thickness was 548.2±49.50 µm preoperatively, and 452.8±56.2 µm and 280.8±62.5 µm at 1 and 12 month follow-up, respectively. Statistical analysis showed significant differences between preoperative and postoperative measurements (p<.05, paired t test) 3 months after injections. Improvement of visual acuity by at least 0.2 LogMAR was seen in 3(50%) of the 6 eyes. No re-injection was needed. In the CRVO group, mean foveal thickness was 543.7±34.4 µm preoperatively, and 283.0±29.0 µm and 234.8±23.6 µm at 1 and 12 month follow-up, respectively. Statistical analysis showed significant differences between preoperative and postoperative measurements (p<.05, paired t test). Improvement of visual acuity by at least 0.2 LogMAR was seen in 7 eyes (88%). Mean number of re-injection was of 2.1±0.3. Intraocular pressure elevation of 22 mm Hg or higher was found in 2/14 eyes (14%). Cataract progression was noted in 5/14 eyes (36%). Conclusions: PST injection of TA appears to be as safe and effective treatment for chronic macular oedema associated due to both non-ischemic BRVO or CRVO, with a better efficacy in BRVO.
Authors and Affiliations
Hoai Viet Tran
Keywords
Related Articles
- EP ID EP556895
- DOI 10.17140/OOJ-1-103
- Views 175
- Downloads 0
Recent Perspectives on Corneal Nerves: A Short Review
This mini-review provides an overview of recent trends in our understanding of the general structure of the cornea, the importance of corneal nerves, their function and distribution in the different layers of the cornea...
Baseline Visual Acuity of Women with Diabetic Macular Edema is Worse than Men: A Case-Control Study
Purpose: To compare the baseline visual and anatomical parameters between the woman and men with diabetic macular edema (DME) who underwent intravitreal ranibizumab treatment. Materials and Methods: This was a retrospect...
Visual Processing Disorder in Children
The minute persons think of eyesight, they generally think about accuracy, as in normal, 6/6 (or 20/20) vision. However, it is much more than that as the brain really processes the visual world, including things like sym...
Fitting Gas Permeable Contact Lens in Keratoconus; Still a Challenge?
Gas permeable (GP) contact lenses (CL) are of paramount importance in keratoconus patient management1 to rehabilitate vision and improve patients’ quality of life (QoL).2 Different surgical and non-surgical options are...
Preferential Hyperacuity Perimetry: Perspectives of Self-Monitoring of Neovascular Activity in Patients with Age-Related Macular Degeneration
The socio-economic burden of age-related macular degeneration (AMD) has strongly increased in public health importance due to the aging of the general population, and in clinics because of the world-wide use of anti-vasc...